九州通：医药电商供应链业务表现强劲，前三季度营收增长近三成

Core Insights - The core focus of the article is on the performance of Jiuzhoutong's retail e-commerce service platform business in the first three quarters of 2025, highlighting significant growth in sales revenue from major pharmaceutical retail e-commerce platforms [1] Group 1: Financial Performance - In the first three quarters of 2025, Jiuzhoutong achieved sales revenue of 6.271 billion yuan, representing a year-on-year growth of 28.92% [1] - Sales revenue from pharmaceuticals and OTC products supplied to JD.com and Alibaba's self-operated platforms reached 4.999 billion yuan, with a year-on-year increase of 29.73% [1] Group 2: Business Development - Jiuzhoutong continues to maintain rapid growth in its supply chain business for health products, serving leading e-commerce platforms such as JD.com, Alibaba, Meituan, Dingdang, Ping An, Douyin, Kuaishou, and Baidu [1]